TIDMINHC
RNS Number : 7037B
Induction Healthcare Group PLC
12 October 2020
12 October 2020
Induction Healthcare Group PLC
("Induction", the "Company", or the "Group")
Strategic Collaboration Between Cerner and Induction
Healthcare
- Value added reseller agreement : NHS Trusts who are Cerner
clients can access Zesty products through their existing
agreements
- Improving patient experience: strategic collaboration to help
NHS hospitals make it easier for patients to manage their
outpatient appointments and correspondence online
Induction, a leading healthcare technology company that helps
healthcare professionals deliver better care more efficiently,
announces a strategic collaboration with Cerner Corporation
(Nasdaq: CERN), a global health care technology company.
Zesty, Induction's market-leading patient portal for hospitals,
and Cerner will develop a joint patient engagement solution to help
NHS trusts deliver an easier, quicker and more efficient service
for patients. This collaboration will closely align existing
patient facing technology in the UK and Ireland, building on the
benefits of Cerner's patient portal solution Healthelife SM and
Zesty's integration capability with Cerner's electronic health
record (EHR), Cerner Millennium(R).
NHS Trusts are expected to help patients manage outpatient
appointments, complete remote care questionnaires, and view
hospital correspondence on their own mobile phones - helping to
reduce delays and costs associated with posting letters, reducing
demands on administrative, medical and nursing staff, and
significantly improving patient experience and access to care
options.
As part of the value added reseller (VAR) agreement, NHS Trusts
that are already Cerner clients will have access to Zesty's
market-leading patient portal under their existing contractual
arrangements.
Cerner is a leader in health care technology interoperability
and embeds standards and guidance in support of open approaches to
data sharing between systems. Cerner was one of the first
signatories of techUK's Health and Social Care Interoperability
Charter, co-founding the UK's INTEROpen interoperability industry
group while championing FHIR(R) in the UK, and having been a
long-time supporter of the Professional Records Standards Body, as
well as its predecessor in the Royal College of Physicians.
This strategic collaboration has the potential to generate
material revenues for Induction in the year ending 31 March 2022,
in keeping with the company's strategic focus.
James Balmain, Joint-CEO of Induction Healthcare, said:
"It is a landmark moment for Zesty to be selected by Cerner in
the UK and Ireland to jointly develop patient engagement solutions
for NHS hospitals. Together, our organisations can provide staff
and patients with world class digital tools to manage their care
and operate more efficiently in the current environment of rapidly
changing and unfamiliar conditions. The prospect of a patient
facing platform that represents the best of Zesty and the best of
Cerner will be game-changing for both existing and new Cerner
customers."
Distie Profit, Managing Director of Cerner UK, said:
"We will all be patients at some stage in our life, which is why
Cerner is committed to providing our clients with scalable and
interoperable solutions that help them create the best possible
experience for their patients. Helping patients become more engaged
and empowered through access to their health information allows
them to receive care remotely and better manage their health."
"This new collaboration with Zesty is expected to provide a more
streamlined experience for both patients and health care
professionals and reaffirms our commitment to improving the
outcomes for all individuals by creating innovative solutions and
collaborations to benefit our clients."
In the UK, Cerner's powerful, open and interoperable Cerner EHR
is utilised by more than144,000 health and care professionals
across 24 NHS Trusts to manage 1.5 million patients every month.
Its Health Information Exchange (HIE) shares more than 19 million
health records, and its population health intelligence platform,
HealtheIntent(R) , is contracted to help clients proactively manage
and improve the health of more than 9.5 million individuals.
ENQUIRIES
Induction Healthcare Via FTI Consulting
Dr Hugo Stephenson, Joint Chief Executive
Officer
James Balmain, Joint Chief Executive Officer
Numis Securities (Nominated Adviser and
Broker) +44 (0) 207 260 1000
James Black / Freddie Barnfield / Huw Jeremy
/ Matthew Jones
FTI Consulting +44 (0) 203 727 1000
Jamie Ricketts / Elena Kalinskaya / Sam Purewal
/ Mary Whittow
About Induction
Induction Healthcare Group PLC is a leading healthcare
technology company that helps healthcare professionals deliver
better care more efficiently. The Group has three platforms,
Induction [Switch] and MicroGuide, that support healthcare
professionals in multiple markets, including the UK, Ireland,
Australia & South Africa, plus Zesty, a leading provider of
patient portals to NHS Hospitals in the UK.
Induction Switch is the number one healthcare collaboration app
in the UK, used by the majority of hospital doctors within the NHS.
The app helps over 140,000 registered users in multiple territories
to increase productivity and enhance communication by securely
sharing phone numbers and bleeps, bookmarks, documents and messages
in a clinical setting.
The MicroGuide platform provides medical organisations with the
ability to collaboratively create, edit, and publish their own
local medical guidelines in a secure and locally administrated
environment. The platform helps over 170,000 registered users in
multiple territories, including the majority of hospital trusts
within the NHS.
The Zesty platform enables patients to manage their care direct
from their smartphone. The Zesty patient portal removes the
friction from everyday health related tasks, like booking and
managing appointments, reading letters digitally and sharing copies
of electronic medical records.
About Cerner
Cerner's health technologies connect people and information
systems in thousands of contracted provider facilities worldwide
dedicated to creating smarter and better care for individuals and
communities.
Recognized globally for innovation, Cerner assists clinicians in
making care decisions and assists organizations in managing the
health of their populations. The company also offers an integrated
clinical and financial system to help manage day-to-day revenue
functions, as well as a wide range of services to support clinical,
financial and operational needs, focused on people. For more
information, visit Cerner.com , The Cerner Blog or connect on
Facebook , Instagram , LinkedIn , Twitter or The Cerner Podcast .
Nasdaq: CERN. Health care is too important to stay the same.
Trademark reference
Zesty and Induction Healthcare logos are registered trademarks
of Induction Healthcare Group PLC. Cerner, Cerner Millennium and
HealtheIntent are registered trademarks of Cerner Corporation or
its affiliates.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
ALLMLBLTMTBMBPM
(END) Dow Jones Newswires
October 12, 2020 02:00 ET (06:00 GMT)
Grafico Azioni Induction Healthcare (LSE:INHC)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Induction Healthcare (LSE:INHC)
Storico
Da Apr 2023 a Apr 2024